Personal Injury News

Doctors Target NexGen Implants For Loosening Early

Since 2003, Zimmer Holdings has sold an impressive 150,000 NexGen CR Flex knee implants. This accounts for 2% of their $1.76 billion total in 2009 sales. Just in terms of sales, the product has been very successful. But their success is not without criticism. Two orthopedic surgeons who practice in Chicago at the Rush University Medical Center say the NexGen implant is loosening early at a high rate and are asking Zimmer to issue a recall, gaining the attention of the United States Senate.

Surgeons Dr. Richard Berger and Dr. Craig Della Valle claim that 36% of the NexGen knee implants, in their experience, loosen within the first two years of implantation and 9.3% require revision surgery due to mobility and pain caused by loosening. Zimmer has responded that the problems are caused by doctors who improperly implant the device.

Barry Meier wrote a report which appeared in the June 18, 2010 issue of the New York Times. It inspired Senator Charles E. Grassley to reach Zimmer CEO David C. Dvorak in a letter dated June 29, 2010. Grassley is a ranking member of the Senate Committee on Finance, which oversees Medicare and Medicaid, among other duties.

As a knee recall lawyer, I encourage you or loved one affected by a NexGen knee implant have your case evaluated by a lawyer, since you may have a claim in the NexGen recall lawsuit.

Comments are closed.